结构连接体的比较,用于建模深度大脑刺激途径激活的模型
Ketan Mehta1, Angela M Noecker1, Cameron C McIntyre2
1Department of Biomedical Engineering, Duke University, Durham, NC, United States.
NeuroImage
|April 13, 2025
概括
不同的大脑连接体显著改变深度大脑刺激 (DBS) 路径预测. 这种变异性质疑连接学DBS研究缺乏验证的可靠性.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医疗成像医学成像
背景情况:
- 结构性大脑连接体对于预测深度大脑刺激 (DBS) 途径至关重要.
- 现有的连接体在技术参数,分片和施工方法上有所不同,导致潜在的不一致性.
研究的目的:
- 为了比较和量化DBS通路激活预测在不同结构连接体的变异性.
- 评估使用相同的电极放置和刺激体积与多种连接体的影响.
主要方法:
- 分析了四个结构连接体:霍恩,耶,彼得森和迈塔尼克.
- 在四个常见的电极位置 (体下核,体下核,腹囊) 进行了DBS模拟.
主要成果:
- 连接组的选择显著影响了DBS通路激活预测,显示的一致性很小.
- 基于轨道图的连接体 (Horn, Yeh) 提供了广泛的覆盖范围,但缺乏解剖学有效性.
- 基于组织学的连接体 (Petersen,Majtanik) 在解剖学上是现实的,但特定于目标.
结论:
- 不一致的DBS网络连接推断引发了人们对连接学DBS研究可靠性的担忧.
- 强调需要在连接性DBS研究中进行解剖学和电生理学验证.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...


